CEFALY provides effective acute migraine treatment at home
The Trial of eTNS for the Acute treatment of Migraine (TEAM) study found that the use of self-administered 2-hour eTNS therapy with CEFALY is a safe and effective therapeutic option, with or without the use of acute anti-migraine medications.
The TEAM study is the largest sham-controlled clinical trial examining the use of any e-TNS therapy for the treatment of migraine headache.
of CEFALY users reported pain freedom after 2 hours of treatment
of CEFALY users reported resolution of their most bothersome migraine symptom
of CEFALY users reported resolution of all migraine symptoms
CEFALY significantly reduces migraine pain
In the Acute Migraine Therapy with External Trigeminal Neurostimulation (ACME) study, patients saw a reduction in migraine pain intensity following a 60-minute ACUTE treatment session with CEFALY. This was a double-blind, randomized, sham-controlled study conducted across multiple headache centers in the U.S.
reduction in migraine pain intensity, on average, following one hour of treatment with CEFALY. This relief continued up to 24 hours
of acute migraine sufferers saw pain relief
of acute migraine sufferers saw pain freedom
CEFALY significantly decreases the number of migraine days
With compliant daily use of CEFALY s 20-minute PREVENT treatment, patients experienced a significant reduction in the number of migraine days, the Migraine Prevention with a Supraorbital Transcutaneous Stimulator (PREMICE) study found.
Adverse events were mild and fully reversible within 20 minutes, without intervention. This was a double-blind, randomized, sham-controlled study conducted across multiple Belgian tertiary headache centers.
38.1% of CEFALY users saw at least a 50% reduction in the number of migraine days.
30% (mean 2.06) reduction in migraine days in verum group.
Who should use CEFALY?
CEFALY is indicated to be used for:
Acute treatment of migraine with or without aura in patients 18 years of age or older
Preventative treatment of episodic migraine with or without aura in patients 18 years of age or older.
CEFALY is ideal for people with migraine who:
Don t respond to pharmaceutical treatments or seek clinically proven effective alternatives to pharmaceuticals.
Have prior medical conditions and are unable to take traditional pharmaceuticals.
Have limited access to outpatient treatment procedures.
4 interest-free payments or as low as $38.27/mo with Affirm. Learn more